GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » C4X Discovery Holdings PLC (FRA:C4J) » Definitions » Debt-to-Equity

C4X Discovery Holdings (FRA:C4J) Debt-to-Equity : 0.01 (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C4X Discovery Holdings Debt-to-Equity?

C4X Discovery Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.30 Mil. C4X Discovery Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.01 Mil. C4X Discovery Holdings's Total Stockholders Equity for the quarter that ended in Jan. 2024 was €28.70 Mil. C4X Discovery Holdings's debt to equity for the quarter that ended in Jan. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for C4X Discovery Holdings's Debt-to-Equity or its related term are showing as below:

FRA:C4J' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.7   Med: 0.04   Max: 0.07
Current: 0.01

During the past 12 years, the highest Debt-to-Equity Ratio of C4X Discovery Holdings was 0.07. The lowest was -1.70. And the median was 0.04.

FRA:C4J's Debt-to-Equity is ranked better than
99.91% of 1065 companies
in the Biotechnology industry
Industry Median: 0.14 vs FRA:C4J: 0.01

C4X Discovery Holdings Debt-to-Equity Historical Data

The historical data trend for C4X Discovery Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C4X Discovery Holdings Debt-to-Equity Chart

C4X Discovery Holdings Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.05 0.02 0.06 0.07

C4X Discovery Holdings Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.06 0.04 0.07 0.01

Competitive Comparison of C4X Discovery Holdings's Debt-to-Equity

For the Biotechnology subindustry, C4X Discovery Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C4X Discovery Holdings's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, C4X Discovery Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where C4X Discovery Holdings's Debt-to-Equity falls into.



C4X Discovery Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

C4X Discovery Holdings's Debt to Equity Ratio for the fiscal year that ended in Jul. 2023 is calculated as

C4X Discovery Holdings's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C4X Discovery Holdings  (FRA:C4J) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


C4X Discovery Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of C4X Discovery Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


C4X Discovery Holdings (FRA:C4J) Business Description

Traded in Other Exchanges
Address
53 Portland Street, Manchester One, Manchester, GBR, M1 3LD
C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sight allows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules.

C4X Discovery Holdings (FRA:C4J) Headlines

No Headlines